Michaela Tyblova

Charles University and General University Hospital in Prague, First Faculty of Medicine

Czech Republic

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (8)

Manuela Vaneckova

Charles University and University Hospital Motol

CZECH REPUBLIC

View details

Anna Kostera-Pruszczyk

Head of Department/Prof.

Medical University of Warsaw

POLAND

View details

Josef Bednarik

professor

University Hospital Brno

CZECH REPUBLIC

View details

Klara Novotna

CZECH REPUBLIC

View details

Jiří Drahota

General University Hospital in Prague

CZECH REPUBLIC

View details

Dominika Stastna

Charles University and General University Hospital in Prague, First Faculty of Medicine

CZECH REPUBLIC

View details

Michala Jakubíková

Charles University, First Faculty of Medicine

CZECH REPUBLIC

View details

Tomas Uher

Všeobecná Fakultní Nemocnice v Praze

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michaela Tyblova

Research Interests

Explore related searches

Contact this professor

Articles (10)

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection

A Randomized, Double-Blind, Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.

Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival

Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis

Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis

Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis

Collaborators (8)

Manuela Vaneckova

Anna Kostera-Pruszczyk

Josef Bednarik

Klara Novotna

Jiří Drahota

Dominika Stastna

Michala Jakubíková

Tomas Uher

Make your next move.